Centro de Estudios Científicos (CECs), Avenida Arturo Prat 514, Valdivia, Chile.
Centro de Estudios Científicos (CECs), Avenida Arturo Prat 514, Valdivia, Chile.
Biochem Biophys Res Commun. 2019 Jun 30;514(3):574-579. doi: 10.1016/j.bbrc.2019.04.169. Epub 2019 May 3.
Kir7.1 is an inwardly rectifying K channel present in epithelia where it shares membrane localization with the Na/K-pump. In the present communication we report the presence of a novel splice variant of Kir7.1 in mouse tissues including kidney, lung, choroid plexus and retinal pigment epithelium (RPE). The variant named mKir7.1-SV2 lacks most of the C-terminus domain but is predicted to have the two transmembrane domains and permeation pathway unaffected. Similarly truncated predicted proteins, Kir7.1-R166X and Kir7.1-Q219X, would arise from mutations associated with Leber Congenital Amaurosis, a rare recessive hereditary retinal disease that results in vision loss at early age. We found that mKir7.1-SV2 and the pathological variants do not produce any channel activity when expressed alone in HEK-293 cells due to their scarce presence in the plasma membrane. Simultaneous expression with the full length Kir7.1 however leads to a reduction in activity of the wild-type channel that might be due to partial proteasome degradation of WT-mutant channel heteromers.
Kir7.1 是一种存在于上皮组织中的内向整流钾通道,与钠/钾泵共享膜定位。在本通讯中,我们报告了在包括肾脏、肺、脉络丛和视网膜色素上皮(RPE)在内的小鼠组织中存在 Kir7.1 的一种新型剪接变异体。该变异体命名为 mKir7.1-SV2 缺失了大部分 C 端结构域,但预计具有不受影响的两个跨膜结构域和渗透途径。同样截短的预测蛋白 Kir7.1-R166X 和 Kir7.1-Q219X 则源于与莱伯先天性黑蒙症相关的突变,这是一种罕见的隐性遗传性视网膜疾病,会导致早期视力丧失。我们发现,mKir7.1-SV2 和病理性变异体在单独表达于 HEK-293 细胞时不会产生任何通道活性,因为它们在质膜中存在较少。然而,与全长 Kir7.1 同时表达会导致野生型通道活性降低,这可能是由于 WT-突变体通道异源二聚体的部分蛋白酶体降解所致。